developer, manufacturer and distributor of pharmaceuticals
Issues related to health care, the Food and Drug Administration (FDA), 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program, education around COVID-19 therapies, antimicrobial resistance legislation, and PDUFA Reauthorization. Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; S.3799, PREVENT Pandemics Act. General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Proposed Part B IPI Demonstration Project; Drug Pricing; Medicaid rebates and AMP Cap; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Reconciliation (H.R.5376); S.2428, False Claims Amendments Act of 2021. Implementation of Tax Cuts and Jobs Act (P.L.115-97). Issues related to pharmaceutical IP and supply chain; S.1260, United States Innovation and Competition Act of 2021; H.R.4521, America COMPETES Act of 2022. Issues related to appropriations and federal health programs; reimbursement and vial size issues; H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103); FY2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations; FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. Biopharmaceutical innovation and patent policy issues. Trademark legislative proposals. Bayh-Dole march-in rights policy issues.
HCR - Health Issues MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code TRD - Trade (domestic/foreign) BUD - Budget/Appropriations CPT - Copyright/Patent/Trademark
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
JOHN GREEN STEWART HALL MATHEW LAPINSKI HUNTER MOORHEAD TODD MATTHEW WEISS BRITTANY JOHNSON HERNANDEZ SALIM ALAMEDDIN JASON GLEASON JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK TODD MATTHEW WEISS JOHN GREEN STEWART HALL MATHEW LAPINSKI HUNTER MOORHEAD BRITTANY JOHNSON HERNANDEZ SALIM ALAMEDDIN JASON GLEASON JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK TODD MATTHEW WEISS JOHN GREEN STEWART HALL MATHEW LAPINSKI HUNTER MOORHEAD SHAY MICHAEL HANCOCK BRITTANY JOHNSON HERNANDEZ SALIM ALAMEDDIN JASON GLEASON JASON BENJAMIN VAN PELT TODD MATTHEW WEISS JOHN GREEN STEWART HALL MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SALIM ALAMEDDIN SHAY MICHAEL HANCOCK BRITTANY JOHNSON HERNANDEZ JASON GLEASON TODD MATTHEW WEISS JOHN GREEN STEWART HALL MATHEW LAPINSKI SHAY MICHAEL HANCOCK HUNTER MOORHEAD SALIM ALAMEDDIN JASON GLEASON BRITTANY JOHNSON HERNANDEZ JASON BENJAMIN VAN PELT TODD MATTHEW WEISS JOHN GREEN STEWART HALL MATHEW LAPINSKI HUNTER MOORHEAD SALIM ALAMEDDIN JASON GLEASON SHAY MICHAEL HANCOCK JASON BENJAMIN VAN PELT BRITTANY JOHNSON HERNANDEZ